Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
NewsWHO News Release
Open Access

WHO URGES COUNTRIES TO INVEST IN ELIMINATING HEPATITIS

Saudi Medical Journal September 2019, 40 (9) 968-969;
  • Article
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

26 July 2019, Geneva - Ahead of World Hepatitis Day (28 July), WHO calls on countries to take advantage of recent reductions in the costs of diagnosing and treating viral hepatitis and scale up investments in disease elimination.

A new study by WHO, published today in Lancet Global Health, has found that investing US$6bn per year in eliminating hepatitis in 67 low- and middle-income countries would avert 4.5 million premature deaths by 2030, and more than 26 million deaths beyond that target date.

A total of US$58.7 billion is needed to eliminate viral hepatitis as a public health threat in these 67 countries by 2030. This means reducing new hepatitis infections by 90% and deaths by 65%.

“Today 80% of people living with hepatitis can’t get the services they need to prevent, test for and treat the disease,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “On World Hepatitis Day, we’re calling for bold political leadership, with investments to match. We call on all countries to integrate services for hepatitis into benefit packages as part of their journey towards universal health coverage.”

By investing in diagnostic tests and medicines for treating hepatitis B and C now, countries can save lives and reduce costs related to long-term care of cirrhosis and liver cancer that result from untreated hepatitis.

Some countries are already taking action. The Government of India, for example, has announced that it will offer free testing and treatment for both hepatitis B and C, as part of its universal health coverage plan. This has been facilitated through the reduction in prices of medicines. In India, a hepatitis C cure costs less than US$40 and a year of hepatitis B treatment costs less than US$30. At these prices, hepatitis C cure will result in healthcare cost savings within three years.

The Government of Pakistan has also been able to procure hepatitis C curative treatment at similarly low prices. Providing curative treatment to all those currently diagnosed with hepatitis C could also reduce healthcare costs in Pakistan within three years. Meanwhile, Pakistan is faced with one of the highest new annual infection rates of hepatitis C virus and is launching a new infection control and injection safety plan on the occasion of World Hepatitis Day to stop transmission.

No access to prevention, testing and treatment for most

For the vast majority of the 325 million people living with hepatitis B and/or C, accessing testing and treatment remains beyond reach.

Of the estimated 257 million living with hepatitis B infection:

  • 10.5% (27 million) knew their infection status in 2016.

  • Of those people diagnosed, only 17% (4.5 million) received treatment in 2016.

  • In 2016, 1.1 million people newly developed chronic hepatitis B infection—a primary cause of liver cancer.

Of the estimated 71 million people living with chronic hepatitis C infection in 2015.

  • 19% (13.1 million) knew their infection status in 2017.

  • Of those people diagnosed, 15% (2 million) received curative treatment in that same year. Overall, between 2014 and 2017, 5 million people have received hepatitis C curative treatment.

  • In 2017, 1.75 million people newly developed chronic hepatitis C infection.

World Hepatitis Day

WHO’s global hepatitis strategy, endorsed by all WHO Member States, aims to reduce new hepatitis infections by 90% and deaths by 65% between 2016 and 2030.

On World Hepatitis Day 2019, WHO calls on all countries to “Invest in eliminating hepatitis” through costing, budgeting and financing of elimination services within their universal health coverage plans. While there has been broad support among WHO Member States in adopting the WHO hepatitis elimination strategy, with 124 out of 194 countries developing hepatitis plans, over 40% of country plans lack dedicated budget lines to support elimination efforts.

WHO has also released online calculators (www.hepccalculator.org and www.hepbcalculator.org) designed to help decision makers to evaluate the cost-effectiveness of their hepatitis treatment programmes.

There are five types of viral hepatitis infections – A, B, C, D and E. Over 95% of deaths are caused by chronic hepatitis B and C infections, while hepatitis A and E rarely cause life-threatening illnesses. Hepatitis D is an additional infection occurring in people living with hepatitis B.

Editor’s note

For World Hepatitis Day 2019 “Invest in eliminating hepatitis”, WHO will be joining the Government of Pakistan in inaugurating the Prime Minister’s Initiative for hepatitis in Islamabad, Pakistan. This is a country with one of the fastest growing hepatitis C epidemics in the world, but also in the process of adopting progressive policies to reverse the tide.

SDG Health Price Tag

In 2017, the SDG Health Price Tag study estimated the investments needed to reach 16 health-related targets of the Sustainable Development Goals in 67 low- and middle-income countries that account for 75% of the world’s population. This study did not include the costing for hepatitis.

The new study published today is based on the same modelling scenarios and methods to estimate the costs of reaching global hepatitis elimination targets.

Available from: https://www.who.int/news-room/detail/26-07-2019-who-urges-countries-to-invest-in-eliminating-hepatitis

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 40 (9)
Saudi Medical Journal
Vol. 40, Issue 9
1 Sep 2019
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
WHO URGES COUNTRIES TO INVEST IN ELIMINATING HEPATITIS
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
WHO URGES COUNTRIES TO INVEST IN ELIMINATING HEPATITIS
Saudi Medical Journal Sep 2019, 40 (9) 968-969;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
WHO URGES COUNTRIES TO INVEST IN ELIMINATING HEPATITIS
Saudi Medical Journal Sep 2019, 40 (9) 968-969;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • WHO launches first-ever guidelines on meningitis diagnosis, treatment and care
  • WHO issues its first-ever reports on tests and treatments for fungal infections
  • WHO brings countries together to test collective pandemic response
Show more WHO News Release

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire